Table 2.
Comparison of Adverse Events at 90 Days Postoperatively Between the OD and ODR Cohorts a
| Complication | OD Cohort (n = 17,139; 40.9%) |
ODR Cohort (n = 24,793; 59.1%)) |
Odds Ratio (95% CI) | P |
|---|---|---|---|---|
| 90-day AAEs | 190 (1.11) | 260 (1.05) | 0.99 (0.81-1.21) | .88 |
| Hematoma | 33 (0.19) | 30 (0.12) | 0.58 (0.35-0.97) | .04 |
| AKI | 33 (0.19) | 36 (0.15) | 0.76 (0.46-1.26) | .28 |
| SSI | 106 (0.62) | 118 (0.48) | 0.81 (0.61-1.07) | .14 |
| Transfusion | 5 (0.03) | 4 (0.02) | 0.82 (0.18-4.17) | .79 |
| Wound dehiscence | 33 (0.19) | 30 (0.12) | 0.98 (0.68-1.43) | .91 |
| Sepsis | 23 (0.13) | 30 (0.12) | 1.02 (0.57-1.90) | .94 |
| DVT | 33 (0.19) | 52 (0.21) | 1.02 (0.65-1.62) | .93 |
| Nerve injury | 15 (0.09) | 24 (0.10) | 1.41 (0.69-3.09) | .36 |
| PE | 18 (0.11) | 38 (0.15) | 1.52 (0.85-2.85) | .17 |
a Data are reported as n (%) unless otherwise indicated. Boldface P value indicates statistical significance (P ≤ .05). Each qualifying patient was only counted once regardless of the number of adverse events the patient experienced in that category. Comparisons were made using multivariate logistic regression, controlling for age, sex, tobacco use, and ECI. AAE, any adverse event; AKI, acute kidney injury; DVT, deep vein thrombosis; ECI, Elixhauser Comorbidity Index; OD, open debridement alone; ODR, open debridement with tendon repair; PE, pulmonary embolism; SSI, surgical site infection.